← Back to Search

Cardiac Rehabilitation plus Transcendental Meditation for Coronary Artery Disease (CCR Trial)

Phase 2
Waitlist Available
Led By Robert H Schneider, M.D.
Research Sponsored by Maharishi International University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

CCR Trial Summary

The overall hypothesis of this study is that a cardiac rehabilitation program with meditation will be more effective than cardiac rehabilitation alone in improving blood flow through the diseased coronary arteries in African Americans. For this purpose, 56 African American men and women with coronary heart disease will be randomly assigned either to standard cardiac rehabilitation plus the Transcendental Meditation program or to standard cardiac rehabilitation alone. The treatment period will be 12 weeks in length.

Eligible Conditions
  • Coronary Artery Disease

CCR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
coronary blood flow as measured by PET
Secondary outcome measures
blood pressure, behavioral risk factors (diet, exercise, substance use) and psychosocial stress factors (depression, social support, general well-being)

CCR Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cardiac Rehabilitation plus Transcendental MeditationExperimental Treatment1 Intervention
a standard validated cardiac rehabilitation program plus a standard validated stress reduction component, the Transcendental Meditation program
Group II: Cardiac RehabilitationActive Control1 Intervention
This control is a standard Cardiac Rehabilitation without a stress reduction technique

Find a Location

Who is running the clinical trial?

Columbia UniversityOTHER
1,433 Previous Clinical Trials
2,447,753 Total Patients Enrolled
12 Trials studying Coronary Artery Disease
14,458 Patients Enrolled for Coronary Artery Disease
Maharishi International UniversityLead Sponsor
9 Previous Clinical Trials
1,548 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
201 Patients Enrolled for Coronary Artery Disease
Robert H Schneider, M.D.Principal InvestigatorMaharishi International University
5 Previous Clinical Trials
1,169 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
201 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in Blacks
Robert Schneider, MD 2009. "A Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in Blacks". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01810029.
All > Heart Disease
~4 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top